Patent Assignment
Reel/Frame 055966/0656
Change of Name
Recorded: 2021-04-19
Pages: 5
Assignor
ADARE PHARMACEUTICALS US, L.P.
Executed: 2020-09-30
Assignee
ELLODI PHARMACEUTICALS, L.P.
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Properties
(5)
Orally Administered Corticosteroid Compositions
Orally Administered Corticosteroid Compositions
Orally Administered Corticosteroid Compositions
Orally Administered Corticosteroid Compositions
Orally Administered Corticosteroid Compositions
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 20, 2010
From: VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 025530/0062 →
Assignment of Assignor's Interest
Dec 20, 2010
From: PERRETT, STEPHEN; COHEN, FREDRIC JAY
To: EURAND PHARMACEUTICALS, INC.
Reel/Frame 025530/0272 →
Security Agreement
Feb 11, 2011
From: EURAND, INCORPORATED
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025783/0548 →
Change of Name
Oct 6, 2011
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH, INC.
Reel/Frame 027028/0048 →
Release of Lien on Patents
Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMATECH, INC.
Reel/Frame 031494/0925 →
Patent Security Agreement
Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release
Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Assignment of Assignor's Interest
Aug 7, 2015
From: PERRETT, STEPHEN; COHEN, FREDRIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 036279/0866 →
Assignment of Assignor's Interest
Aug 7, 2015
From: PERRETT, STEPHEN; COHEN, FREDRIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 036279/0804 →
Change of Name
Aug 7, 2015
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH INC.
Reel/Frame 036314/0231 →
Change of Name
Aug 7, 2015
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH INC.
Reel/Frame 036314/0203 →
Change of Name
Sep 28, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036702/0042 →
U.S. Patent Security Agreement
Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Assignment of Assignor's Interest
Aug 4, 2017
From: PERRETT, STEPHEN; COHEN, FREDERIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 043202/0964 →
Change of Name
Aug 4, 2017
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 043203/0001 →
Change of Name
Aug 4, 2017
From: EURAND INCORPORATED
To: APTALIS PHARMATECH INC.
Reel/Frame 043202/0977 →
Assignment of Assignor's Interest
Dec 4, 2018
From: ADARE PHARMACEUTICALS, INC.
To: ADARE DEVELOPMENT I, L.P,
Reel/Frame 047672/0450 →
Assignment of Assignor's Interest
Dec 5, 2018
From: PERRETT, STEPHEN; COHEN, FREDERIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 047678/0051 →
Change of Name
Dec 5, 2018
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 047720/0520 →
Change of Name
Dec 5, 2018
From: EURAND INCORPORATED
To: APTALIS PHARMATECH INC.
Reel/Frame 047720/0492 →
Security Interest
Dec 18, 2018
From: ADARE DEVELOPMENT I, L.P.
To: BANK OF MONTREAL
Reel/Frame 047807/0967 →
Change of Name
Jan 7, 2020
From: ADARE DEVELOPMENT I., L.P.
To: ADARE PHARMACEUTICALS US, L.P.
Reel/Frame 051491/0920 →
Change of Name
Jul 16, 2020
From: ADARE DEVELOPMENT I, L.P.
To: ADARE PHARMACEUTICALS US, L.P.
Reel/Frame 053228/0251 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276
Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Corrective Assignment to Correct the Application Number, Patent Issue Date and the Title Previously Recorded at Reel: 053228 Frame: 0251. Assignor(S) Hereby Confirms the Assignment.
Oct 5, 2020
From: ADARE DEVELOPMENT I, L.P.
To: ADARE PHARMACEUTICALS US, L.P.
Reel/Frame 054003/0694 →